The Board of China Vanguard Group Limited announced that the company has settled the outstanding loan including all outstanding principal amount and all outstanding interests due to Tarascon Asia Absolute Fund (Cayman) Ltd. on 24 January 2014. Pursuant to the deed of release and discharge dated 28 January 2014, the receivership was terminated on 28 January 2014.
Sinopharm Tech Holdings Limited
Equities
8156
KYG2159V1418
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.097 HKD | -8.49% |
|
-17.80% | -26.52% |
02-29 | Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
2023 | Sinopharm Tech Holdings Limited Announces Management Changes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.52% | 2.49M | |
-4.90% | 182B | |
-1.36% | 104B | |
-4.01% | 67.64B | |
+9.30% | 46.44B | |
-7.64% | 45.58B | |
+9.63% | 44.34B | |
+13.63% | 29.44B | |
+20.29% | 26.8B | |
-7.12% | 23.82B |
- Stock Market
- Equities
- 8156 Stock
- News Sinopharm Tech Holdings Limited
- China Vanguard Group Limited Announces Settlement of Outstanding Loan